Navigation Links
Blood Glucose Testing and Diabetes Management - Dramatic Increase in the Incidence of Diabetes
Date:4/2/2013

DUBLIN, April 2, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Blood Glucose Testing and Diabetes Management" report to their offering.

     (Photo: http://photos.prnewswire.com/prnh/20130307/600769 )

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease - sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes - the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the world. As such, the global market for blood glucose testing products is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, certain segments of the market, such as home testing devices for diabetes management, will exhibit strong growth. What's more, non-invasive testing now represents a major new area for the application of IVD testing. Additionally, direct access testing - or over-the-counter testing, which allows consumers to order tests themselves without visiting a doctor`- has emerged as a strong force in the blood glucose testing segment.

The purpose of this TriMark Publications report is to describe the specific market segments for blood glucose testing and diabetes management. This study reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum or plasma or whole-blood glucose concentrations. Moreover, it examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations.

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Glucose Diagnostic and Monitoring Recommendations

5. Glucose Testing Technology Platforms and Consumable Products

6. Glucose Testing Devices on the Market

7. Business Trends in Glucose Testing

8. Technology Trends

9. Company Profiles

Companies Mentioned:

- Abaxis, Inc.

- Abbott Laboratories

- ACON Laboratories

- AgaMatrix

- Alere

- All Medicus

- Amedica Biotech

- A. Menarini Diagnostics

- Apex Biotechnology Corporation

- ARKRAY

- Bayer

- B. Braun Melsungen

- Beckman Coulter

- Bionime

- Bio-Rad Laboratories, Inc.

- BioTex

- Calisto Medical

- Cambridge Sensors

- DexCom

- Diagnostic Devices/Prodigy Diabetes Care

- DiaSys

- Echo Therapeutics

- Entra Health Systems

- Fora Care

- Genesis Health Technologies

- GenExel-Sein

- GlucoPlus

- GluMetris

- GlySens

- Hainice Medical

- HemoCue (a Quest Diagnostics company)

- Home Diagnostics

- Infopia

- IN4 Technology

- International Techidyne Corporation (ITC)

- Instrumentation Laboratory Company

- i-Sens

- Johnson & Johnson

- Luminous Medical

- Medtronic

- Nipro Corporation

- Nova Biomedical

- OrSense

- Polymer Technology Systems

- Radiometer Medical

- Roche

- 77 Elektronika Kft.

- Siemens AG

- Smiths Group

- Stanbio Laboratory

- TaiDoc Technology

- Techno Medica Co., Ltd.

- US Diagnostics

- VeraLight

For more information visit http://www.researchandmarkets.com/research/j49msm/blood_glucose

Research and Markets
Laura Wood , Senior Manager,
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Received AABB Accreditation
2. Cellular Therapy and Cord Blood 2013 Market Report
3. Stem Cell / Regenerative Medicine & HSCT / Cord Blood Market Analysis in New Research Report at ReportsnReports.com
4. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
5. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
6. Dr. Carlos Szajnert, Announced today his Commitment to Further Educate his Patients on the Benefits of Cord Blood Stem Cells
7. UCLA researchers further refine NanoVelcro device to grab single cancer cells from blood
8. The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
9. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
10. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
11. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/24/2016)... 2016  Regular discussions on a range of subjects including ... two entities said Poloz. Speaking at a lecture ... , he pointed to the country,s inflation target, which is ... "In certain areas there ... common economic goals, why not sit down and address strategy ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):